| Victor Appiah, MD | |
|
500 W Jubal Early Drive, Suite 110, Winchester, VA 22601-6507 | |
| (540) 667-2100 | |
| (540) 667-2577 |
| Full Name | Victor Appiah |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 500 W Jubal Early Drive, Winchester, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366496762 | NPI | - | NPPES |
| 010111706 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101235209 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Winchester Medical Center | Winchester, VA | Hospital |
| Entity Name | Family Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437239886 PECOS PAC ID: 5890745384 Enrollment ID: O20050122000062 |
News Archive
The study may also provide an evolutionary explanation for differences in populations living farther away from the Equator. Human ancestors may have undergone this change in R72 to promote energy storage in cold climates and during times of famine. However, in modern society, the need for this type of variant in our genes is unnecessary, leading instead to increased risk for obesity and type 2 diabetes. Obesity is also a risk factor for certain types of cancer, so these findings may also explain why the R72 variant of p53 might predispose certain people to cancer.
Particle Works – a Blacktrace Holdings brand – is a world leader in the synthesis of nano- and microparticles. Combining state-of-the-art facilities with precision manufacturing expertise, the company can offer a wide range of bespoke services, including high throughput material discovery, process optimization and synthesis scale-up.
UT Southwestern Medical Center researchers have identified compounds that appear to inhibit a signaling pathway in Huntington's disease, a finding that may eventually lead to a potential drug therapy to help slow the progression of degenerative nerve disorders.
Acorda Therapeutics, Inc. today announced that it has received marketing approval from the U.S. Food and Drug Administration (FDA) for AMPYRA™ (dalfampridine), an oral treatment to improve walking in patients with multiple sclerosis (MS).
Since the beginning of the year across the state of Rio, 49 people have died from the potentially deadly fever, the vast majority of victims have been in the city itself, with hospitals struggling to cope.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Victor Appiah, MD 500 W Jubal Early Drive, Suite 110, Winchester, VA 22601-6507 Ph: (540) 667-2100 | Victor Appiah, MD 500 W Jubal Early Drive, Suite 110, Winchester, VA 22601-6507 Ph: (540) 667-2100 |
News Archive
The study may also provide an evolutionary explanation for differences in populations living farther away from the Equator. Human ancestors may have undergone this change in R72 to promote energy storage in cold climates and during times of famine. However, in modern society, the need for this type of variant in our genes is unnecessary, leading instead to increased risk for obesity and type 2 diabetes. Obesity is also a risk factor for certain types of cancer, so these findings may also explain why the R72 variant of p53 might predispose certain people to cancer.
Particle Works – a Blacktrace Holdings brand – is a world leader in the synthesis of nano- and microparticles. Combining state-of-the-art facilities with precision manufacturing expertise, the company can offer a wide range of bespoke services, including high throughput material discovery, process optimization and synthesis scale-up.
UT Southwestern Medical Center researchers have identified compounds that appear to inhibit a signaling pathway in Huntington's disease, a finding that may eventually lead to a potential drug therapy to help slow the progression of degenerative nerve disorders.
Acorda Therapeutics, Inc. today announced that it has received marketing approval from the U.S. Food and Drug Administration (FDA) for AMPYRA™ (dalfampridine), an oral treatment to improve walking in patients with multiple sclerosis (MS).
Since the beginning of the year across the state of Rio, 49 people have died from the potentially deadly fever, the vast majority of victims have been in the city itself, with hospitals struggling to cope.
› Verified 5 days ago
Barbara Anne Harris Feshami, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 170 Prosperity Dr, Winchester, VA 22602 Phone: 540-869-0600 | |
Katelyn Nicewander, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 607 E Jubal Early Dr, Winchester, VA 22601 Phone: 540-536-2232 | |
Mrs. Angela Lynn Titus, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 172 Linden Dr Ste 107, Winchester, VA 22601 Phone: 540-678-0767 Fax: 540-678-0769 | |
Dr. Arthur Sterling Ticknor, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Merchant St Ste 100, Winchester, VA 22603 Phone: 540-536-5560 Fax: 540-536-5561 | |
Brendan Michael Flynn, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 W Cork St Unit 405, Winchester, VA 22601 Phone: 540-313-9200 | |
Dr. Sean Sutphen, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 607 E Jubal Early Dr, Winchester, VA 22601 Phone: 540-536-2232 Fax: 540-536-2206 | |
Sam Waltos, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 104 Selma Dr, Winchester, VA 22601 Phone: 540-678-2800 Fax: 540-667-0652 |